• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2015年至2023年重度三尖瓣反流成像与治疗策略的文献计量分析

Bibliometric analysis of imaging and treatment strategies for severe tricuspid regurgitation from 2015 to 2023.

作者信息

Schlegl Johannes, Bannehr Marwin, Kücken Tanja, Jankowska Paulina, Neuss Michael, Lichtenauer Michael, Haase-Fielitz Anja, Butter Christian, Edlinger Christoph

机构信息

Department of Cardiology, University Hospital Heart Center Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Neuruppin, Germany.

Faculty of Health Sciences Brandenburg, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.

出版信息

Front Cardiovasc Med. 2024 Oct 29;11:1444466. doi: 10.3389/fcvm.2024.1444466. eCollection 2024.

DOI:10.3389/fcvm.2024.1444466
PMID:39534496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11554479/
Abstract

BACKGROUND

Severe tricuspid regurgitation is a progressive disease with an unfavourable prognosis. In recent years there have been extraordinary gains in knowledge through both clinical and basic scientific work. We performed a bibliometric analysis on tricuspid regurgitation with a focus on imaging techniques and treatment approaches and to identify scientific milestones and emerging research trends.

METHODS

Publications, published between 2015 and 2023 were identified. Study characteristics, impact factors and countries of origin studies were recorded. Heat maps were created to visualise data and to identify leading centers. Most frequently cited publications were recognised as milestones.

RESULTS

We screened 3,519 studies. 368 studies were included, of which 326 were clinical studies. Clinical studies were further subdivided into interventional ( = 138), surgical ( = 115) or studies on imaging modalities ( = 74). We detected an enormous increase in scientific output worldwide, especially in imaging and interventional studies. The United States, Germany and Poland were identified as leading countries in imaging, interventions and preclinical studies respectively.

CONCLUSIONS

Our study reflects the global gain in knowledge over the last 9 years. We were able to identify an annually rising number of interventional studies. Imaging studies have also seen a rapid increase, especially since 2020. In recent years, we monitored a decline in surgical studies.

摘要

背景

严重三尖瓣反流是一种预后不良的进行性疾病。近年来,通过临床和基础科学研究,我们在这方面的知识有了显著增长。我们对三尖瓣反流进行了文献计量分析,重点关注成像技术和治疗方法,以确定科学里程碑和新兴研究趋势。

方法

确定2015年至2023年期间发表的文献。记录研究特征、影响因素和研究的原产国。创建热图以可视化数据并确定领先中心。最常被引用的文献被视为里程碑。

结果

我们筛选了3519项研究。纳入368项研究,其中326项为临床研究。临床研究进一步细分为介入性研究(=138项)、外科研究(=115项)或成像方式研究(=74项)。我们发现全球科学产出大幅增加,尤其是在成像和介入性研究方面。美国、德国和波兰分别被确定为成像、干预和临床前研究的领先国家。

结论

我们的研究反映了过去9年全球知识的增长。我们发现介入性研究的数量逐年增加。成像研究也迅速增加,尤其是自2020年以来。近年来,我们监测到外科研究数量有所下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/1cc7a310218b/fcvm-11-1444466-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/d2a6459cff89/fcvm-11-1444466-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/a87955c8e2b0/fcvm-11-1444466-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/69e1088b1cff/fcvm-11-1444466-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/8ced74de221d/fcvm-11-1444466-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/b7e024980c9b/fcvm-11-1444466-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/5fd183463c9c/fcvm-11-1444466-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/66e9a0b355a5/fcvm-11-1444466-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/6de42aa79931/fcvm-11-1444466-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/ec0ecf176b96/fcvm-11-1444466-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/c48d47abd088/fcvm-11-1444466-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/952b809d9997/fcvm-11-1444466-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/c490d595052a/fcvm-11-1444466-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/1cc7a310218b/fcvm-11-1444466-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/d2a6459cff89/fcvm-11-1444466-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/a87955c8e2b0/fcvm-11-1444466-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/69e1088b1cff/fcvm-11-1444466-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/8ced74de221d/fcvm-11-1444466-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/b7e024980c9b/fcvm-11-1444466-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/5fd183463c9c/fcvm-11-1444466-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/66e9a0b355a5/fcvm-11-1444466-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/6de42aa79931/fcvm-11-1444466-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/ec0ecf176b96/fcvm-11-1444466-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/c48d47abd088/fcvm-11-1444466-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/952b809d9997/fcvm-11-1444466-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/c490d595052a/fcvm-11-1444466-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b298/11554479/1cc7a310218b/fcvm-11-1444466-g013.jpg

相似文献

1
Bibliometric analysis of imaging and treatment strategies for severe tricuspid regurgitation from 2015 to 2023.2015年至2023年重度三尖瓣反流成像与治疗策略的文献计量分析
Front Cardiovasc Med. 2024 Oct 29;11:1444466. doi: 10.3389/fcvm.2024.1444466. eCollection 2024.
2
Multimodality Imaging in the Management of Tricuspid Valve Regurgitation.三尖瓣反流的多模态影像学管理。
Echocardiography. 2024 Oct;41(10):e15960. doi: 10.1111/echo.15960.
3
Tricuspid Regurgitation: A Review of Current Interventional Management.三尖瓣反流:当前介入治疗管理的综述。
J Am Heart Assoc. 2024 Mar 19;13(6):e032999. doi: 10.1161/JAHA.123.032999. Epub 2024 Mar 12.
4
Parkinson's Disease Treatment: A Bibliometric Analysis.帕金森病治疗:文献计量分析
Cureus. 2024 Sep 17;16(9):e69613. doi: 10.7759/cureus.69613. eCollection 2024 Sep.
5
Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk.高手术风险的有症状瓣膜反流患者的二尖瓣和三尖瓣联合瓣 versus 单纯二尖瓣瓣环成形术。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1142-1151. doi: 10.1016/j.jcin.2018.04.010.
6
Predictors of Procedural and Clinical Outcomes in Patients With Symptomatic Tricuspid Regurgitation Undergoing Transcatheter Edge-to-Edge Repair.经导管缘对缘修复术治疗症状性三尖瓣反流患者的操作和临床结局的预测因素。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1119-1128. doi: 10.1016/j.jcin.2018.05.002.
7
Edge-to-Edge Repair for Tricuspid Valve Regurgitation. Preliminary Echo-Data and Clinical Implications from the Tricuspid Regurgitation IMAging (TRIMA) Study.三尖瓣反流的边缘对边缘修复。三尖瓣反流成像(TRIMA)研究的初步超声心动图数据及临床意义
J Clin Med. 2022 Sep 23;11(19):5609. doi: 10.3390/jcm11195609.
8
Global Research on Hereditary Hearing Impairment Over the Last 40 Years: A Bibliometric Study.四十年遗传性听力障碍全球研究:文献计量学研究。
J Int Adv Otol. 2021 Nov;17(6):482-491. doi: 10.5152/iao.2021.21276.
9
An overview of surgical treatment modalities and emerging transcatheter interventions in the management of tricuspid valve regurgitation.三尖瓣反流治疗中手术治疗方式及新兴经导管介入治疗概述
Expert Rev Cardiovasc Ther. 2018 Feb;16(2):75-89. doi: 10.1080/14779072.2018.1421068. Epub 2018 Jan 15.
10
Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study.经导管缘对缘修复术减少三尖瓣反流:TRILUMINATE 单臂研究的 6 个月结果。
Lancet. 2019 Nov 30;394(10213):2002-2011. doi: 10.1016/S0140-6736(19)32600-5. Epub 2019 Nov 7.

本文引用的文献

1
Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions: Validation of TRISCORE.经导管三尖瓣介入治疗后死亡率和心力衰竭住院的预测:TRISCORE 的验证。
JACC Cardiovasc Interv. 2024 Apr 8;17(7):859-870. doi: 10.1016/j.jcin.2024.02.013.
2
New Approaches to Assessment and Management of Tricuspid Regurgitation Before Intervention.新方法评估和干预前三尖瓣反流的管理。
JACC Cardiovasc Interv. 2024 Apr 8;17(7):837-858. doi: 10.1016/j.jcin.2024.02.034.
3
Transcatheter treatment of the tricuspid valve: current status and perspectives.
经导管三尖瓣治疗:现状与展望。
Eur Heart J. 2024 Mar 14;45(11):876-894. doi: 10.1093/eurheartj/ehae082.
4
Two-Year Outcomes for Tricuspid Repair With a Transcatheter Edge-to-Edge Valve Repair From the Transatlantic TRILUMINATE Trial.经导管缘对缘修复三尖瓣的两年结果:来自跨大西洋 TRILUMINATE 试验。
Circ Cardiovasc Interv. 2023 Aug;16(8):e012888. doi: 10.1161/CIRCINTERVENTIONS.122.012888. Epub 2023 Aug 15.
5
Fate of concomitant tricuspid regurgitation in patients undergoing coronary artery bypass grafting.行冠状动脉旁路移植术患者合并三尖瓣反流的转归。
J Thorac Cardiovasc Surg. 2024 Sep;168(3):853-860.e2. doi: 10.1016/j.jtcvs.2023.07.044. Epub 2023 Aug 2.
6
1-Year Outcomes of Transcatheter Tricuspid Valve Repair.经导管三尖瓣修复术的 1 年结果。
J Am Coll Cardiol. 2023 May 9;81(18):1766-1776. doi: 10.1016/j.jacc.2023.02.049.
7
Impact of socioeconomic aspects on cardiac implantable electronic device treatment and application of the EHRA guidelines : A European comparison.社会经济因素对心脏植入式电子设备治疗的影响及欧洲心脏病学会(EHRA)指南的应用:一项欧洲比较研究
Wien Klin Wochenschr. 2022 Sep;134(17-18):646-653. doi: 10.1007/s00508-022-02056-5. Epub 2022 Aug 2.
8
Prognostic Value of Modified Model for End-Stage Liver Disease Score in Patients Undergoing Isolated Tricuspid Valve Replacement.终末期肝病评分改良模型在接受单纯三尖瓣置换术患者中的预后价值
Front Cardiovasc Med. 2022 Jul 1;9:932142. doi: 10.3389/fcvm.2022.932142. eCollection 2022.
9
6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study.三尖瓣系统治疗三尖瓣反流患者的 6 个月结果:TRICUS EURO 研究。
JACC Cardiovasc Interv. 2022 Jul 11;15(13):1366-1377. doi: 10.1016/j.jcin.2022.05.022. Epub 2022 May 17.
10
Transcatheter Tricuspid Valve Replacement With the EVOQUE System: 1-Year Outcomes of a Multicenter, First-in-Human Experience.EVOQUE 系统行经导管三尖瓣置换术:多中心、首例人体研究的 1 年结果。
JACC Cardiovasc Interv. 2022 Mar 14;15(5):481-491. doi: 10.1016/j.jcin.2022.01.280.